The latest update is out from Omega Therapeutics ( (OMGA) ).
Omega Therapeutics, Inc. has appointed Robert L. Rosiello to its Board of Directors, with immediate effect from October 2, 2024. He will receive a $35,000 annual retainer and an option to buy 50,000 shares of company stock at $1.09 each, which will vest over three years. Rosiello’s appointment is based solely on merit, without any prior arrangements or familial ties to current directors or officers, and he holds no conflicting material interests.
Learn more about OMGA stock on TipRanks’ Stock Analysis page.
